Annual Total Debt:
$649.47M-$484.41M(-42.72%)Summary
- As of today (September 13, 2025), BMRN annual total debt is $649.47 million, with the most recent change of -$484.41 million (-42.72%) on December 31, 2024.
- During the last 3 years, BMRN annual total debt has fallen by -$473.92 million (-42.19%).
- BMRN annual total debt is now -44.70% below its all-time high of $1.17 billion, reached on December 31, 2017.
Performance
BMRN Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$611.88M+$2.06M(+0.34%)Summary
- As of today (September 13, 2025), BMRN quarterly total debt is $611.88 million, with the most recent change of +$2.06 million (+0.34%) on June 30, 2025.
- Over the past year, BMRN quarterly total debt has dropped by -$487.76 million (-44.36%).
- BMRN quarterly total debt is now -59.34% below its all-time high of $1.50 billion, reached on September 30, 2020.
Performance
BMRN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
BMRN Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -42.7% | -44.4% |
3 y3 years | -42.2% | -43.4% |
5 y5 years | -28.6% | -59.3% |
BMRN Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -42.7% | at low | -46.0% | +0.3% |
5 y | 5-year | -42.7% | at low | -59.3% | +0.3% |
alltime | all time | -44.7% | >+9999.0% | -59.3% | >+9999.0% |
BMRN Total debt History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $611.88M(+0.3%) |
Mar 2025 | - | $609.82M(-6.1%) |
Dec 2024 | $649.47M(-42.7%) | $649.47M(+6.4%) |
Sep 2024 | - | $610.18M(-44.5%) |
Jun 2024 | - | $1.10B(+0.3%) |
Mar 2024 | - | $1.10B(-3.3%) |
Dec 2023 | $1.13B(+1.2%) | $1.13B(+4.4%) |
Sep 2023 | - | $1.09B(+0.1%) |
Jun 2023 | - | $1.08B(+0.1%) |
Mar 2023 | - | $1.08B(-3.2%) |
Dec 2022 | $1.12B(-0.3%) | $1.12B(+3.5%) |
Sep 2022 | - | $1.08B(+0.1%) |
Jun 2022 | - | $1.08B(+0.1%) |
Mar 2022 | - | $1.08B(-3.9%) |
Dec 2021 | $1.12B(-0.7%) | $1.12B(+4.2%) |
Sep 2021 | - | $1.08B(+0.1%) |
Jun 2021 | - | $1.08B(+0.1%) |
Mar 2021 | - | $1.08B(-4.9%) |
Dec 2020 | $1.13B(+24.4%) | $1.13B(-24.8%) |
Sep 2020 | - | $1.50B(+0.2%) |
Jun 2020 | - | $1.50B(+64.4%) |
Mar 2020 | - | $913.45M(+0.4%) |
Dec 2019 | $909.62M(+9.5%) | $909.62M(+0.1%) |
Sep 2019 | - | $908.88M(+0.6%) |
Jun 2019 | - | $903.21M(+1.3%) |
Mar 2019 | - | $891.93M(+7.4%) |
Dec 2018 | $830.42M(-29.3%) | $830.42M(-30.8%) |
Sep 2018 | - | $1.20B(+0.7%) |
Jun 2018 | - | $1.19B(+0.7%) |
Mar 2018 | - | $1.18B(+0.7%) |
Dec 2017 | $1.17B(+71.9%) | $1.17B(+0.7%) |
Sep 2017 | - | $1.17B(+72.4%) |
Jun 2017 | - | $676.21M(-2.1%) |
Mar 2017 | - | $690.93M(+1.1%) |
Dec 2016 | $683.24M(+3.2%) | $683.24M(+1.1%) |
Sep 2016 | - | $675.64M(+0.8%) |
Jun 2016 | - | $670.11M(+0.3%) |
Mar 2016 | - | $668.01M(+0.9%) |
Dec 2015 | $662.29M(+0.7%) | $662.29M(-0.8%) |
Sep 2015 | - | $667.79M(+1.0%) |
Jun 2015 | - | $661.49M(+0.9%) |
Mar 2015 | - | $655.49M(-0.4%) |
Dec 2014 | $657.98M(+0.4%) | $657.98M(+0.2%) |
Sep 2014 | - | $656.88M(+0.9%) |
Jun 2014 | - | $650.87M(-1.6%) |
Mar 2014 | - | $661.42M(+0.9%) |
Dec 2013 | $655.57M(+88.3%) | $655.57M(+737.1%) |
Sep 2013 | - | $78.31M(-28.7%) |
Jun 2013 | - | $109.82M(-0.0%) |
Mar 2013 | - | $109.85M(-68.5%) |
Dec 2012 | $348.22M(-0.0%) | $348.22M(-0.0%) |
Sep 2012 | - | $348.30M(-0.0%) |
Jun 2012 | - | $348.31M(-0.0%) |
Mar 2012 | - | $348.33M(-0.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $348.33M(-7.7%) | $348.33M(-0.0%) |
Sep 2011 | - | $348.34M(-7.7%) |
Jun 2011 | - | $377.52M(-0.0%) |
Mar 2011 | - | $377.52M(0.0%) |
Dec 2010 | $377.52M(-24.1%) | $377.52M(-24.1%) |
Sep 2010 | - | $497.08M(0.0%) |
Jun 2010 | - | $497.08M(0.0%) |
Mar 2010 | - | $497.08M(-0.0%) |
Dec 2009 | $497.17M(-0.0%) | $497.17M(+0.0%) |
Sep 2009 | - | $497.08M(-0.0%) |
Jun 2009 | - | $497.26M(-0.0%) |
Mar 2009 | - | $497.31M(-0.0%) |
Dec 2008 | $497.35M(-0.0%) | $497.35M(-0.2%) |
Sep 2008 | - | $498.44M(+0.2%) |
Jun 2008 | - | $497.44M(+0.0%) |
Mar 2008 | - | $497.30M(-0.0%) |
Dec 2007 | $497.38M(+122.1%) | $497.38M(0.0%) |
Sep 2007 | - | $497.38M(0.0%) |
Jun 2007 | - | $497.38M(+188.3%) |
Mar 2007 | - | $172.50M(-23.0%) |
Dec 2006 | $223.94M(+53.5%) | $223.94M(0.0%) |
Sep 2006 | - | $223.94M(-24.7%) |
Jun 2006 | - | $297.50M(-6.3%) |
Mar 2006 | - | $317.44M(+117.6%) |
Dec 2005 | $145.91M(+0.6%) | $145.91M(-0.7%) |
Sep 2005 | - | $146.90M(-0.7%) |
Jun 2005 | - | $147.98M(-0.5%) |
Mar 2005 | - | $148.71M(+2.5%) |
Dec 2004 | $145.09M(+13.0%) | $145.09M(+9.9%) |
Sep 2004 | - | $131.99M(+2.5%) |
Jun 2004 | - | $128.78M(+3.0%) |
Mar 2004 | - | $125.00M(-2.6%) |
Dec 2003 | $128.39M(+2078.7%) | $128.39M(+2.7%) |
Sep 2003 | - | $125.00M(0.0%) |
Jun 2003 | - | $125.00M(+1527.0%) |
Mar 2003 | - | $7.68M(+30.4%) |
Dec 2002 | $5.89M(+6.1%) | $5.89M(>+9900.0%) |
Sep 2002 | - | $0.00(0.0%) |
Jun 2002 | - | $0.00(-100.0%) |
Mar 2002 | - | $5.22M(-6.0%) |
Dec 2001 | $5.55M(+6589.2%) | $5.55M(+2203.7%) |
Sep 2001 | - | $241.00K(-18.6%) |
Jun 2001 | - | $296.00K(+289.5%) |
Mar 2001 | - | $76.00K(-8.4%) |
Dec 2000 | $83.00K(-25.2%) | $83.00K(-8.8%) |
Sep 2000 | - | $91.00K(-6.2%) |
Jun 2000 | - | $97.00K(-5.8%) |
Mar 2000 | - | $103.00K(-7.2%) |
Dec 1999 | $111.00K(-17.3%) | $111.00K(-17.2%) |
Sep 1999 | - | $134.00K(-99.5%) |
Jun 1999 | - | $26.12M(>+9900.0%) |
Mar 1999 | - | $128.30K(-4.4%) |
Dec 1998 | $134.20K(>+9900.0%) | - |
Dec 1998 | - | $134.20K |
Dec 1997 | $0.00 | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual total debt?
- What is the all time high annual total debt for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual total debt year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly total debt?
- What is the all time high quarterly total debt for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly total debt year-on-year change?
What is BioMarin Pharmaceutical Inc. annual total debt?
The current annual total debt of BMRN is $649.47M
What is the all time high annual total debt for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual total debt is $1.17B
What is BioMarin Pharmaceutical Inc. annual total debt year-on-year change?
Over the past year, BMRN annual total debt has changed by -$484.41M (-42.72%)
What is BioMarin Pharmaceutical Inc. quarterly total debt?
The current quarterly total debt of BMRN is $611.88M
What is the all time high quarterly total debt for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly total debt is $1.50B
What is BioMarin Pharmaceutical Inc. quarterly total debt year-on-year change?
Over the past year, BMRN quarterly total debt has changed by -$487.76M (-44.36%)